Radcliffe Capital Management, L.P. - LAVA MEDTECH ACQUISITION COR ownership

LAVA MEDTECH ACQUISITION COR's ticker is and the CUSIP is 519345102. A total of 48 filers reported holding LAVA MEDTECH ACQUISITION COR in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of LAVA MEDTECH ACQUISITION COR
ValueSharesWeighting
Q1 2023$2,079,221
+56.5%
199,350
+53.8%
0.13%
+209.5%
Q4 2022$1,328,277
+2.0%
129,5880.0%0.04%
+35.5%
Q3 2022$1,302,000
+0.9%
129,588
+0.1%
0.03%
+3.3%
Q2 2022$1,290,000
+1.7%
129,489
+1.7%
0.03%
+3.4%
Q1 2022$1,269,000
+26.9%
127,269
+27.3%
0.03%
+11.5%
Q4 2021$1,000,000100,0000.03%
Other shareholders
LAVA MEDTECH ACQUISITION COR shareholders Q2 2022
NameSharesValueWeighting ↓
Castle Creek Arbitrage, LLC 600,000$6,114,0000.54%
Governors Lane LP 490,000$5,022,5000.52%
PERISCOPE CAPITAL INC. 770,515$7,906,1350.34%
CVI Holdings, LLC 201,315$2,069,5180.26%
Shaolin Capital Management LLC 700,000$7,1330.21%
Atlas Merchant Capital LLC 122,400$1,258,2720.20%
SONA ASSET MANAGEMENT (US) LLC 60,000$611,4000.18%
Context Capital Management, LLC 225,000$2,3060.17%
Bulldog Investors, LLP 53,500$546,8050.16%
Saba Capital Management, L.P. 1,073,662$11,005,0360.15%
View complete list of LAVA MEDTECH ACQUISITION COR shareholders